Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 236Carcinoma, Non-Small-Cell Lung 78Carcinoma, Renal Cell 61Neoplasm Metastasis 52Neoplasms 47Prostatic Neoplasms 34Uveal Melanoma 29Lung Neoplasms 28Pancreatic Neoplasms 27Carcinoma, Hepatocellular 25Brain Neoplasms 23Sarcoma 22Colorectal Neoplasms 21Breast Neoplasms 20Squamous Cell Carcinoma of Head and Neck 18Small Cell Lung Carcinoma 18Skin Neoplasms 17Kidney Neoplasms 17Diabetes Mellitus, Insulin-Dependent, 12 17Carcinoma, Transitional Cell 17Ovarian Neoplasms 15Triple Negative Breast Neoplasms 14Urinary Bladder Neoplasms 13Mesothelioma 13Uterine Cervical Neoplasms 12Recurrence 12Glioblastoma 12Multiple Myeloma 11Lymphoma 11Clear-cell metastatic renal cell carcinoma 11

Interventions

Radiotherapy 29Cisplatin 12Amifostine 11Radiotherapy, Intensity-Modulated 7Paclitaxel 7Carboplatin 7Etoposide 5Radiosurgery 4Donepezil 4Brachytherapy 4Bevacizumab 4sargramostim 3Surgical Procedures, Operative 3Mental Status and Dementia Tests 3Filgrastim 3Diet Therapy 3Blood Specimen Collection 3Radiation Dose Hypofractionation 2Radiation 2Proton Therapy 2Magnetic Resonance Spectroscopy 2Low-Level Light Therapy 2Lithium 2Hyperbaric Oxygenation 2Heavy Ion Radiotherapy 2Fluorouracil 2Fibroblast Growth Factor 7 2Dexamethasone 2Chemotherapy, Adjuvant 2Androgen Antagonists 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Radiation Injuries × Ipilimumab × Clear all
NCT02406183 2017-01-10

Trial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma

University Hospital, Ghent

Phase 1 Completed
13 enrolled
Dermatologic

Melanoma, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡